| 000455 (2003) |
Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
| 000157 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 000219 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000569 (1998) |
Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy |
| 000087 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder | AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. |
| 000200 (2010) |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000209 (2010) |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease |
| 000217 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000267 (2009) |
Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni] | Adherence to antiparkinson medication in a multicenter European study |
| 000308 (2008) |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000314 (2007) |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000353 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
| 000360 (2006) |
Emmanuel Roze [France] ; Marie Vidailhet [France] ; Nenad Blau [Suisse] ; Lisbeth Birk Moller [Danemark] ; Diane Doummar [France] ; Thierry Billette De Villemeur [France] ; Anne Roubergue [France] | Long‐term follow‐up and adult outcome of 6‐pyruvoyl‐tetrahydropterin synthase deficiency |
| 000369 (2006) |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 000647 (1993) |
H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France] | Symptomatic effect of selegiline in De Novo Parkinsonian patients |
| 000098 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. Moline | Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. |
| 000147 (2011) |
Eric Bardinet [France] ; Hayat Belaid [France] ; David Grabli [France] ; Marie-Laure Welter [France] ; Sara Fernandez Vidal [France] ; Damien Galanaud [France] ; Stéphane Derrey [France] ; Didier Dormont [France] ; Philippe Cornu [France] ; Jérôme Yelnik [France] ; Carine Karachi [France] | Thalamic stimulation for tremor: Can target determination be improved? |
| 000166 (2011) |
Peggy Reiner [France] ; Damien Galanaud [France] ; Gaëlle Leroux [France] ; Marie Vidailhet [France] ; Julien Haroche [France] ; Du Le Thi Huong [France] ; Camille Francès [France] ; Thomas Papo [France] ; Christian De Gennes [France] ; Lucile Musset [France] ; Bertrand Wechsler [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Nathalie Costedoat-Chalumeau [France] | Long‐term outcome of 32 patients with chorea and systemic lupus erythematosus or antiphospholipid antibodies |
| 000198 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 000206 (2010) |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
| 000303 (2008) |
Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France] | Are parkin patients particularly suited for deep‐brain stimulation? |
| 000312 (2007) |
Adeline Gallini [France] ; Agnès Sommet [France] ; Anne-Marie Salandini [France] ; Patrick Veyssière [France] ; Jean-Louis Montastruc [France] ; Jean-Louis Montastruc [France] | Weight‐loss associated with anti‐dementia drugs in a patient with Parkinson's disease |
| 000317 (2007) |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease: A double‐blind placebo‐controlled trial |
| 000322 (2007) |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease |
| 000383 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 000406 (2005) |
Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End‐of‐dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double‐blind study |
| 000428 (2004) |
Frédéric Macia [France] ; Caroline Perlemoine [France] ; Irène Coman [France] ; Dominique Guehl [France] ; Pierre Burbaud [France] ; Emmanuel Cuny [France] ; Henri Gin [France] ; Vincent Rigalleau [France] ; François Tison [France] | Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight |
| 000508 (2001) |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
| 000545 (1999) |
Yves Agid [France] ; E. Ahlskog [France] ; A. Albanese [France] ; D. Calne [France] ; T. Chase [France] ; J. De Yebenes [France] ; S. Factor [France] ; S. Fahn [France] ; O. Gershanik [France] ; C. Goetz [France] ; W. Koller [France] ; M. Kurth [France] ; A. Lang [France] ; A. Lees [France] ; P. Lewitt [France] ; D. Marsden [France] ; E. Melamed [France] ; P. P. Michel [France] ; Y. Mizuno [France] ; J. Obeso [France] ; W. Oertel [France] ; W. Olanow [France] ; Werner Poewe [France] ; Pierre Pollak [France] ; S. Przedzorski [France] ; N. Quinn [France] ; R. Raisman-Vozari [France] ; A. Rajput [France] ; F. Stocchi [France] ; E. Tolosa [France] | Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint |
| 000552 (1999) |
Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France] | A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
| 000558 (1999) |
H. Widner [Suède] ; G.-L. Defer [France] | Dyskinesias assessment : From CAPIT to CAPSIT |
| 000560 (1998) |
Korczyn [Israël] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Warner H. Poewe [Autriche] ; Olivier Rascol [France] ; Fabrizzio Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study |
| 000561 (1998) |
Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study |
| 000628 (1994) |
J. L. Montastruc [France] ; N. Fabre [France] ; Olivier Rascol [France] ; J. M. Senard [France] ; O. Blin [France] | N‐methyl‐D‐aspartate (NMDA) antagonist and Parkinson's disease: A pilot study with dextromethorphan |
| 000629 (1994) |
Rascol [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Janet Poulik [France] ; Umberto Sabatini [France] ; Jean-Michel Senard [France] ; Michèle Ané [France] ; Jean-Louis Montastruc [France] ; André Rascol [France] | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 000630 (1994) |
Roberto Marconi [France, Italie] ; Dominique Lefebvre-Caparros [France] ; Anne-Marie Bonnet [France] ; Marie Vidailhet [France] ; Bruno Dubois [France] ; Agid [France] | Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology |
| 000644 (1993) |
M. Vidailhet [France] ; C. Bouchard [France] ; P. J. Jedynak [France] ; M. Serdaru [France] | Acute and long‐term response to apomorphine in cranial dystonia |
| 000652 (1992) |
Jean-Fra Ois De Saint Victor [France] ; Pierre Pollak [France] ; Claire-Lise Gervason [France] ; Jean Perret [France] | Levodopa‐induced diphasic dyskinesias improved by subcutaneous apomorphine |
| 000654 (1992) |
Emre [Suisse] ; U. K. Rinne [Finlande] ; A. Rascol [France] ; A. Lees [Royaume-Uni] ; Yves Agid [France] ; X. Lataste [Suisse] | Effects of a selective partil D1 agonist, CY 208‐243, in de novo patients with Parkinson disease |
| 000022 (2015) |
Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe Verny | A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease. |
| 000043 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 000052 (2013) |
Katia Youssov [France] ; Guillaume Dolbeau ; Patrick Maison ; Marie-Françoise Boissé ; Laurent Cleret De Langavant ; Raymund A C. Roos ; Anne-Catherine Bachoud-Lévi | Unified Huntington's disease rating scale for advanced patients: validation and follow-up study. |
| 000065 (2013) |
Renaud Chambon [France] ; Sandrine Vuillaumier-Barrot ; Nathalie Seta ; Sabrina Wagner ; Catherine Sarret | Partial effectiveness of acetazolamide in a mild form of GLUT1 deficiency: a pediatric observation. |
| 000073 (2013) |
Ludy C. Shih [États-Unis] ; Veronique G. Vanderhorst [États-Unis] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada, France] | Improvement of Pisa syndrome with contralateral pedunculopontine stimulation |
| 000103 (2012) |
Wassilios G. Meissner [France] ; Alexandra Foubert-Samier ; Sandrine Dupouy ; Angélique Gerdelat-Mas ; Rachel Debs ; Fabienne Marquant ; Valérie Cochen De Cock ; Olivier Rascol ; François Tison ; Anne Pavy-Le Traon | Assessment of quality of life with the multiple system atrophy health-related quality of life scale. |
| 000104 (2012) |
Cecilia Marelli [France] ; Julie Figoni ; Perrine Charles ; Mathieu Anheim ; Maya Tchikviladze ; Carlo-Maria Vincitorio ; Sophie Tezenas Du Montcel ; Alexis Brice ; Jean Louis Golmard ; Alexandra Dürr | Annual change in Friedreich's ataxia evaluated by the Scale for the Assessment and Rating of Ataxia (SARA) is independent of disease severity. |
| 000145 (2011) |
Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease |
| 000146 (2011) |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
| 000155 (2011) |
Ellis Chan [France] ; Perrine Charles [France] ; Pascale Ribai [France] ; Cyril Goizet [France] ; Cecilia Marelli [France] ; Carlo-Maria Vincitorio [France] ; Alice Le Bayon [France] ; Lucie Guyant-Maréchal [France] ; Nadia Vandenberghe [France] ; Mathieu Anheim [France] ; David Devos [France] ; Leorah Freeman [France] ; Isabelle Le Ber [France] ; Karine N'Guyen [France] ; Maya Tchikviladzé [France] ; Pierre Labauge [France] ; Didier Hannequin [France] ; Alexis Brice [France] ; Alexandra Durr [France] ; Sophie Tezenas Du Montcel [France] | Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias |
| 000179 (2011) |
Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France] | Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study |
| 000199 (2010) |
Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis] | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
| 000205 (2010) |
Tiphaine Rouaud [France] ; Thibaut Dondaine [France] ; Sophie Drapier [France] ; Claire Haegelen [France] ; François Lallement [France] ; Julie Péron [France] ; Sylvie Raoul [France] ; Paul Sauleau [France] ; Marc Vérin [France] | Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation |
| 000231 (2009) |
Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
| 000240 (2009) |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
| 000249 (2009) |
David Grabli [France] ; Claire Ewenczyk [France] ; Maria-Clara Coelho-Braga [France] ; Christelle Lagrange [France] ; Valerie Fraix [France] ; Philippe Cornu [France] ; Alim-Louis Benabid [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] | Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia |
| 000260 (2009) |
Paul Sauleau [France] ; Emmanuelle Leray [France] ; Tiphaine Rouaud [France] ; Sophie Drapier [France] ; Dominique Drapier [France] ; Sophie Blanchard [France] ; Gwenolla Drillet [France] ; Julie Péron [France] ; Marc Vérin [France] | Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease |
| 000287 (2008) |
David Maltête [France] ; Stéphane Derrey [France] ; Nathalie Chastan [France] ; Bertrand Debono [France] ; Emmanuel Gérardin [France] ; Pierre Fréger [France] ; Bruno Mihout [France] ; Jean François Menard [France] ; Didier Hannequin [France] | Microsubthalamotomy: An immediate predictor of long‐term subthalamic stimulation efficacy in Parkinson disease |
| 000298 (2008) |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study |
| 000302 (2008) |
Mouna Ben Djebara [France] ; Yulia Worbe [France] ; Michael Schüpbach [France] ; Andreas Hartmann [France] | Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndrome |
| 000318 (2007) |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study |
| 000320 (2007) |
Pierre Krystkowiak [France] ; Sophie Tezenas Du Montcel [France] ; Laurent Vercueil [France] ; Jean-Luc Houeto [France] ; Christelle Lagrange [France] ; Philippe Cornu [France] ; Serge Blond [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Marie Vidailhet [France] | Reliability of the Burke‐Fahn‐Marsden scale in a multicenter trial for dystonia |
| 000328 (2007) |
Michael W. M. Schüpbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltête [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
| 000329 (2007) |
Mathieu Anheim [France] ; Valérie Fraix [France] ; Stéphan Chabardès [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease |
| 000339 (2007) |
Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France] | Does ageing influence deep brain stimulation outcomes in Parkinson's disease? |
| 000357 (2006) |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 000358 (2006) |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 000361 (2006) |
Marion Simonetta-Moreau [France] ; George Lourenço [France] ; Sophie Sangla [France] ; Leonor Mazieres [France] ; Marie Vidailhet [France] ; Sabine Meunier [France] | Lack of inhibitory interaction between somatosensory afferent inputs and intracortical inhibitory interneurons in focal hand dystonia |
| 000380 (2006) |
Servane Mouton [France] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Gustavo Polo [France] ; Philippe Damier [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | Chorea induced by globus pallidus externus stimulation in a dystonic patient |
| 000395 (2005) |
Alexis Elbaz [États-Unis, France] ; Brett J. Peterson [États-Unis] ; James H. Bower [États-Unis] ; Ping Yang [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Walter A. Rocca [États-Unis] | Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study |
| 000398 (2005) |
Djamel Ben Smail [France] ; Claire Jacq [France] ; Pierre Denys [France] ; Bernard Bussel [France] | Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia |
| 000400 (2005) |
Stéphane Chapuis [France] ; Lemlih Ouchchane [France] ; Olivier Metz [France] ; Laurent Gerbaud [France] ; Franck Durif [France] | Impact of the motor complications of Parkinson's disease on the quality of life |
| 000402 (2005) |
Anne Doé De Maindreville [France] ; Gilles Fénelon [France] ; Florence Mahieux [France] | Hallucinations in Parkinson's disease: A follow‐up study |
| 000415 (2005) |
Stephane Thobois [Royaume-Uni, France] ; Stephen Tisch [Royaume-Uni] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Marwan I. Hariz [Royaume-Uni] ; Isabelle Benatru [France] ; Emmanuel Broussolle [France] ; Patricia Limousin-Dowsey [Royaume-Uni] | Can chronic subthalamic nucleus stimulation induce de novo tremor in Parkinson's disease? |
| 000424 (2004) |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 000444 (2003) |
Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne, France] ; Florian Kopper [Allemagne] ; Monika Pötter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] | Two‐year follow‐up of subthalamic deep brain stimulation in Parkinson's disease |
| 000464 (2002) |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
| 000467 (2002) |
Laurent Vercueil [France] ; Paul Krack [France] ; Pierre Pollak [France] | Results of deep brain stimulation for dystonia: A critical reappraisal |
| 000468 (2002) |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
| 000470 (2002) |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
| 000474 (2002) |
Bernard Pillon [France] | Neuropsychological assessment for management of patients with deep brain stimulation |
| 000478 (2002) |
Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France] | Long‐Term follow‐up of globus pallidus chronic stimulation in advanced Parkinson's disease |
| 000481 (2002) |
Abdelhamid Benazzouz [France] ; Sorin Breit [France] ; Adnan Koudsie [France] ; Pierre Pollak [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] | Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease |
| 000488 (2002) |
Anne-Catherine Bachoud-Lévi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France] | Fetal neural grafts for Huntington's disease: A prospective view |
| 000491 (2002) |
Günther Deuschl [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [France] | Deep brain stimulation for movement disorders |
| 000493 (2002) |
Jean-Pascal Lefaucheur [France] ; Anne-Catherine Bachoud-Levi [France] ; Catherine Bourdet [France] ; Thierry Grandmougin [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Jean-Denis Degos [France] ; Marc Peschanski [France] ; Fabrice Lisovoski [France] | Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease |
| 000495 (2002) |
Pierre-François Pradat [France] ; François Salachas [France] ; Lucette Lacomblez [France] ; Nathalie Patte [France] ; Nadine Leforestier [France] ; Véronique Gaura [France] ; Vincent Meininger [France] | Association of chorea and motor neuron disease |
| 000502 (2001) |
S. Thobois [France] ; E. Broussolle [France] ; L. Toureille [France] ; C. Vial [France] | Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy |
| 000506 (2001) |
Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Modafinil and pramipexole‐associated somnolence |
| 000510 (2001) |
Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease |
| 000511 (2001) |
E. Apartis [France] ; F. Tison [France] ; P. Arné [France] ; C. P. Jedynak [France] ; M. Vidailhet [France] | Fast orthostatic tremor in Parkinson's disease mimicking primary orthostatic tremor |
| 000512 (2001) |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 000518 (2000) |
Jean-Louis Montastruc [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 000535 (1999) |
Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 000550 (1999) |
Patrick Chariot [France] ; Pierre Brugières [France] ; Marie-Christine Eliezer-Vanerot [France] ; Christian Gény [France] ; Michel Binaghi [France] ; Pierre Césaro [France] | Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy |
| 000553 (1999) |
M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France] | The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease |
| 000556 (1999) |
Olivier Rascol [France] | L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease : A clinical pharmacologic approach |
| 000557 (1999) |
P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France] | Dyskinesias assessment in phase II studies |
| 000566 (1998) |
Paul Krack [Allemagne] ; Günther Deuschl [Allemagne] ; Reiner Benecke [Allemagne] ; Andres O. Ceballos-Baumann [Allemagne] ; Marie-Hélène Marion [France] ; Rue Léon Delhomme [France] ; Wolfgang H. Oertel [Allemagne] ; Werner Poewe [Autriche] ; K. Wohlfarth [Allemagne, France, Autriche, Italie, États-Unis] ; H. Göschel [Allemagne, France, Autriche, Italie, États-Unis] ; J. Frevert [Allemagne, France, Autriche, Italie, États-Unis] ; R. Dengler [Allemagne, France, Autriche, Italie, États-Unis] ; H. Bigalke [Allemagne, France, Autriche, Italie, États-Unis] ; Pasquale Montagna [Italie] ; Elio Lugaresi [Italie] ; Stanley Fahn [États-Unis] ; Virgilio Gerald H. Evidente [États-Unis] ; Katrina A. Gwinn [États-Unis] | Letters to the Editor |
| 000568 (1998) |
Nguyen ; B. Pollin [France] ; A. Fève ; C. Geny ; P. Cesaro | Improvement of action tremor by chronic cortical stimulation |
| 000572 (1998) |
Potagas [France] ; George Dellatolas [France] ; Marc Ziegler [France] ; Jean Leveteau [France] ; Nguyen Bathien [France] ; Patrick Mac Leod [France] ; Pierre Rondot [France] | Clinical assessment of olfactory dysfunction in Parkinson's disease |
